Oxford Pharmascience Group Plc (LON:OXP)‘s stock had its “corporate” rating reissued by equities researchers at N+1 Singer in a research report issued on Wednesday.

Separately, Beaufort Securities downgraded Oxford Pharmascience Group Plc to a “hold” rating in a research note on Thursday, July 21st.

Oxford Pharmascience Group Plc (LON:OXP) opened at 1.985 on Wednesday. The firm’s 50-day moving average price is GBX 2.25 and its 200 day moving average price is GBX 4.07. Oxford Pharmascience Group Plc has a 1-year low of GBX 1.86 and a 1-year high of GBX 7.89. The firm’s market capitalization is GBX 23.93 million.

About Oxford Pharmascience Group Plc

Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations.

Receive News & Stock Ratings for Oxford Pharmascience Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Pharmascience Group Plc and related stocks with our FREE daily email newsletter.